Results 301 to 310 of about 154,631 (333)
Some of the next articles are maybe not open access.
Seminars in Hematology, 2001
Tumor lysis syndrome (TLS) is a constellation of metabolic disturbances observed in tumors with high cell turnover. It is associated with significant morbidity and mortality. TLS is characterized by the increased release of intracellular contents (uric acid, potassium, phosphorus) into the extracellular compartment, which can overwhelm the body's ...
openaire +2 more sources
Tumor lysis syndrome (TLS) is a constellation of metabolic disturbances observed in tumors with high cell turnover. It is associated with significant morbidity and mortality. TLS is characterized by the increased release of intracellular contents (uric acid, potassium, phosphorus) into the extracellular compartment, which can overwhelm the body's ...
openaire +2 more sources
Seminars in Oncology, 2001
Abstract The electrolyte abnormalities and metabolic derangements associated with ATLS are a serious consequence in patients with both hematologic malignancies and solid tumors. While concern is primarily for those with highly proliferative hematopoietic disorders following treatment with exquisitely responsive chemotherapy, the practitioner should ...
openaire +2 more sources
Abstract The electrolyte abnormalities and metabolic derangements associated with ATLS are a serious consequence in patients with both hematologic malignancies and solid tumors. While concern is primarily for those with highly proliferative hematopoietic disorders following treatment with exquisitely responsive chemotherapy, the practitioner should ...
openaire +2 more sources
Tumor Lysis Syndrome in Solid Tumors
Supportive Cancer Therapy, 2005Tumor lysis syndrome (TLS) consists of acute hyperuricemic nephropathy, hyperphosphatemia, hypocalcemia, hyperkalemia, and increased serum creatinine. It can be part of the disease presentation, especially in aggressive hematologic malignancies, or a part of the chemotherapy response. There are relatively few reports of TLS in solid tumors.
Frank E, Mott +3 more
openaire +2 more sources
Nursing Made Incredibly Easy!, 2010
Tumor lysis syndrome(TLS)is a serious complication of anti-cancer chemotherapy due to the spontaneous or therapyrelated rapid lysis of malignant cells. TLS is characterized by hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia, which result in acute renal failure and metabolic acidosis.
openaire +3 more sources
Tumor lysis syndrome(TLS)is a serious complication of anti-cancer chemotherapy due to the spontaneous or therapyrelated rapid lysis of malignant cells. TLS is characterized by hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia, which result in acute renal failure and metabolic acidosis.
openaire +3 more sources
Gan to kagaku ryoho. Cancer & chemotherapy, 2009
Recently, the ASCO guideline has added TLS. Prevention and recognition of the disease and state are important. Molecular targeting drugs, small molecule tyrosine kinase inhibitors and monoclonal antibodies induced rapid regression of the tumors and carry a risk of TLS.
openaire +1 more source
Recently, the ASCO guideline has added TLS. Prevention and recognition of the disease and state are important. Molecular targeting drugs, small molecule tyrosine kinase inhibitors and monoclonal antibodies induced rapid regression of the tumors and carry a risk of TLS.
openaire +1 more source
Brain and other central nervous system tumor statistics, 2021
Ca-A Cancer Journal for Clinicians, 2021Kimberly D Miller +2 more
exaly
Understanding tumor lysis syndrome
Intensive Care Medicine, 2019Lara, Zafrani +2 more
openaire +2 more sources
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Ca-A Cancer Journal for Clinicians, 2021Michael L Cheng +2 more
exaly